← Mechanisms of action
SLC6A3
SINGLE PROTEINHomo sapiens
Preferred name: Dopamine transporter ChEMBL ↗
Linked proteins
Drugs acting on this target (31)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| cocaine (Erythroxyline) | Antagonist | approved | Small molecule | SLC6A3 antagonist |
| serdexmethylphenidate (AZSTARYS) | Antagonist | approved | Small molecule | SLC6A3 antagonist |
| ioflupane i-123 | Binding agent | approved | Small molecule | SLC6A3 binding agent |
| modafinil (provigil) | Binding agent | approved | Small molecule | SLC6A3 binding agent |
| altropane | Inhibitor | experimental | Small molecule | SLC6A3 inhibitor |
| amitifadine | Inhibitor | experimental | Small molecule | SLC6A3 inhibitor |
| ansofaxine | Inhibitor | experimental | Small molecule | SLC6A3 inhibitor |
| apo-methylphenidate | Inhibitor | experimental | Small molecule | SLC6A3 inhibitor |
| armodafinil (nuvigil) | Inhibitor | approved | Small molecule | SLC6A3 inhibitor |
| bupropion (wellbutrin) | Inhibitor | approved | Small molecule | SLC6A3 inhibitor |
| dexmethylphenidate (focalin) | Inhibitor | approved | Small molecule | SLC6A3 inhibitor |
| diethylpropion hydrochloride (tenuate) | Inhibitor | approved | Small molecule | SLC6A3 inhibitor |
| gsk372475 | Inhibitor | experimental | Small molecule | SLC6A3 inhibitor |
| ibogaine | Inhibitor | experimental | Small molecule | SLC6A3 inhibitor |
| ip2018 | Inhibitor | experimental | Small molecule | SLC6A3 inhibitor |
| js1-1-01 | Inhibitor | experimental | Small molecule | SLC6A3 inhibitor |
| lbt-999 | Inhibitor | experimental | Small molecule | SLC6A3 inhibitor |
| methylphenidate (ritalin) | Inhibitor | approved | Small molecule | SLC6A3 inhibitor |
| modafinil (provigil) | Inhibitor | approved | Small molecule | SLC6A3 inhibitor |
| phendimetrazine (plegine) | Inhibitor | approved | Small molecule | SLC6A3 inhibitor |
| phenmetrazine (preludin) | Inhibitor | approved | Small molecule | SLC6A3 inhibitor |
| Pudafensine | Inhibitor | experimental | Small molecule | SLC6A3 inhibitor |
| rti-336 | Inhibitor | experimental | Small molecule | SLC6A3 inhibitor |
| serdexmethylphenidate (AZSTARYS) | Inhibitor | approved | Small molecule | Dopamine transporter inhibitor |
| solriamfetol (Sunosi) | Inhibitor | approved | Small molecule | SLC6A3 inhibitor |
| tedatioxetine | Inhibitor | experimental | Small molecule | SLC6A3 inhibitor |
| vanoxerine | Inhibitor | experimental | Small molecule | SLC6A3 inhibitor |
| 3,4-Methylenedioxymethamphetamine | Releasing agent | experimental | Small molecule | Sodium-dependent dopamine transporter releasing agent |
| amphetamine (Adderall) | Releasing agent | approved | Small molecule | SLC6A3 releasing agent |
| dextroamphetamine (Dexedrine) | Releasing agent | approved | Small molecule | SLC6A3 releasing agent |
| lisdexamfetamine (vyvanse) | Releasing agent | approved | Small molecule | SLC6A3 releasing agent |